Gimenes Lima Gabrielle, Portilho Amanda Izeli, De Gaspari Elizabeth
Immunology Center, Adolfo Lutz Institute, São Paulo 01246-902, SP, Brazil.
Graduate Program Interunits in Biotechnology, University of São Paulo, São Paulo 05508-900, SP, Brazil.
Pathogens. 2022 Dec 23;12(1):20. doi: 10.3390/pathogens12010020.
Since late 2019 and early 2020, with the emergence of the COVID-19 pandemic, scientists are rushing to develop treatment and prevention methods to combat SARS-CoV-2. Among these are vaccines. In view of this, the use of animals as experimental models, both to investigate the immunopathology of the disease and to evaluate the efficacy and safety of vaccines, is mandatory. This work aims to describe, through recent scientific articles found in reliable databases, the animal models used for the in vivo testing of COVID-19 vaccines, demonstrating some possibilities of more advantageous/gold-standard models for SARS-CoV-2 vaccines. The majority of the studies use rodents and primates. Meanwhile, the most adequate model to be used as the gold standard for in vivo tests of COVID-19 vaccines is not yet conclusive. Promising options are being discussed as new tests are being carried out and new SARS-CoV-2 variants are emerging.
自2019年末和2020年初新冠疫情出现以来,科学家们急于开发对抗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的治疗和预防方法。其中包括疫苗。有鉴于此,使用动物作为实验模型来研究该疾病的免疫病理学以及评估疫苗的有效性和安全性是必不可少的。这项工作旨在通过在可靠数据库中找到的近期科学文章,描述用于新冠疫苗体内测试的动物模型,展示一些对SARS-CoV-2疫苗更具优势/金标准模型的可能性。大多数研究使用啮齿动物和灵长类动物。与此同时,用作新冠疫苗体内测试金标准的最合适模型尚无定论。随着新测试的开展和新的SARS-CoV-2变体的出现,有前景的选择正在被讨论。